[How to prevent completely ovarian hyperstimulation with GnRH-based stimulation protocols].
Kol
S
S
Department of Obstetrics and Gynecology, IVF Unit, Rambam Medical Center, PO Box 9602, Haifa 31906, Israel.
D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D002985:Clinical Protocols; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D043373:Follicle Stimulating Hormone, Human; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000517:prevention & control*; D010062:Ovulation Induction / Q000379:methods*; D011247:Pregnancy; D011994:Recombinant Proteins / Q000627:therapeutic use; D017329:Triptorelin Pamoate / Q000819:agonists
D006063:Chorionic Gonadotropin; D043373:Follicle Stimulating Hormone, Human; D011994:Recombinant Proteins; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D005640:Follicle Stimulating Hormone